Company Overview and News


Add XON
to your dashboard

Headline News

Featured Company News - Zymeworks Enters Into License Agreement with Janssen Biotech to Develop and Commercialize Next Generation Bispecific Antibody Therapeutics

2017-11-15 accesswire
LONDON, UK / ACCESSWIRE / November 15, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Zymeworks Inc. (NYSE: ZYME), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=ZYME. The Company announced on November 13, 2017, that it has entered into a licensing agreement with Janssen Biotech, Inc. (26-0)

Intrexon (XON) in Focus: Stock Moves 6.5% Higher

2017-11-14 zacks
Intrexon Corporation (XON - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 29.9% in the past one-month time frame. (39-0)

Intrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss

2017-11-10 zacks
Intrexon Corporation (XON - Free Report) reported adjusted loss of 20 cents per share in the third quarter of 2017, which was narrower than the Zacks Consensus Estimate of a loss of 22 cents. (23-0)

Intrexon's (XON) CEO Randal Kirk on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good afternoon, and welcome to the Intrexon Third Quarter 2017 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. (11-0)

Intrexon Corporation to Host Earnings Call

2017-11-09 accesswire
(11-0)

Key Predictions for Q3 Earnings Reports of PBYI, XON, LGND

2017-11-08 zacks
The third-quarter reporting cycle is drawing to a close. Quarterly results have been strong. Overall, the beat percentage is in line with the recent quarters but growth rates have been particularly impressive. Also, the estimate revision trend for Q4 has been mostly favorable. (135-0)

What's in Store for Intrexon (XON) This Earnings Season?

2017-10-31 zacks
Intrexon Corporation (XON - Free Report) is expected to report third-quarter 2017 results on Nov 6 after the market closes. (86-0)

BRIEF-Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals

2017-10-23 reuters
* Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals (11-0)

Fibrocell Science: A Very Appealing Gene Therapy Play

2017-10-19 seekingalpha
Shares may have risen by over 50% year to date, but they are still in the red by almost 70% over the past three years. (67-2)

Oxitec do Brasil Receives Prestigious Award for Innovation and Impact

2017-10-11 prnewswire
Oxitec do Brasil, a subsidiary of Oxitec Ltd, UK, has been presented with the Empreendetec Award in the enterprise category recognizing the results of Oxitec's technology and its contribution to the Piracicaba community and Brazil. The awarding body, ESALQTec from Esalq/USP (Luiz de Queiroz Agriculture College from University of São Paulo), is a technological incubator that brings together companies with innovative projects in the areas of agriculture, biology and information technology. (11-0)

Oxitec to Build State-of-the-Art Mosquito Egg Production Unit

2017-09-19 prnewswire
UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendly™ Aedes Mosquito Eggs per Week (26-0)

Stock Performance Review on Biotech Industry -- Intrexon, Ampio Pharma, AmpliPhi Biosciences, and CorMedix

2017-09-19 prnewswire
If you want a Stock Review on XON, AMPE, APHB, or CRMD then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, the NASDAQ Composite ended the day at 6,454.64, up 0.10%; the Dow Jones Industrial Average edged 0.28% higher, to finish at 22,331.35; and the S&P 500 closed at 2,503.87, marginally gaining 0.15%. US markets saw four out of nine sectors finishing the day in green, 2 in red, and 3 in neutral territory. (91-1)

Biotech Sector Looking to Outperform in 2017

2017-09-14 prnewswire
Biotech is a thriving industry, driven by constant innovation and a search for daring new solutions to serious health problems. After several years of struggle, with smaller companies losing out to rising costs and once-favored stocks taking a beating amidst bearish conditions, biotech is set for a comeback. Leading biotechs in focus include: Amgen Inc. (NASDAQ: AMGN), Medtronic plc (NYSE: MDT), Epizyme, Inc. (13-3)

Is Intrexon Corporation Stock Now a Bargain?

2017-09-13 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. (1-1)

Where Does Zika Virus Vaccine Research Stand Now?

2017-08-14 wire.kapitall
After a lull, the Zika virus was back in headlines early last week, as the Florida Department of Health confirmed the first sexually transmitted Zika case of 2017 in Pinellas County.

CUSIP: 46122T102